Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3317691
Max Phase: Preclinical
Molecular Formula: C24H22N4
Molecular Weight: 366.47
Molecule Type: Small molecule
Associated Items:
ID: ALA3317691
Max Phase: Preclinical
Molecular Formula: C24H22N4
Molecular Weight: 366.47
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cc1cc2c3ccccc3cc(CCc3nc(-c4ccccc4)cn3C)n2n1
Standard InChI: InChI=1S/C24H22N4/c1-17-14-23-21-11-7-6-10-19(21)15-20(28(23)26-17)12-13-24-25-22(16-27(24)2)18-8-4-3-5-9-18/h3-11,14-16H,12-13H2,1-2H3
Standard InChI Key: BWAVCWOIDAVRCM-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 366.47 | Molecular Weight (Monoisotopic): 366.1844 | AlogP: 4.98 | #Rotatable Bonds: 4 |
Polar Surface Area: 35.12 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 5.95 | CX LogP: 4.93 | CX LogD: 4.91 |
Aromatic Rings: 5 | Heavy Atoms: 28 | QED Weighted: 0.45 | Np Likeness Score: -1.07 |
1. Dore A, Asproni B, Scampuddu A, Pinna GA, Christoffersen CT, Langgård M, Kehler J.. (2014) Synthesis and SAR study of novel tricyclic pyrazoles as potent phosphodiesterase 10A inhibitors., 84 [PMID:25016376] [10.1016/j.ejmech.2014.07.020] |
Source(1):